STAT3 and hepatocellular carcinoma: In HCC, activation of the IL‐6/STAT3 pathway directly enhances the expression of TIMP‐1 in liver cancer cells, converting normal hepatic fibroblasts to cancer‐associated fibroblasts, thus altering the tumour microenvironment and promoting tumourigenesis.